Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
2023 · Scientific Reports · 18 citations
https://doi.org/10.1038/s41598-023-45815-8
H
How‐Wen Ko
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
204
Citations
9
h-index
8
i10-index
How‐Wen Ko is an academic researcher from Chang Gung University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Epigenetics and DNA Methylation & Cancer-related gene regulation. The author has an h-index of 9, co-authored 69 publications.
ORCID: 0000-0002-6415-2965Papers by this author
worksAssociation of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation
2022 · Frontiers in Immunology · 14 citations
https://doi.org/10.3389/fimmu.2022.1011092
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study
2024 · Environmental Health · 3 citations
https://doi.org/10.1186/s12940-024-01070-6
Plasma phenylalanine is associated with hospital mortality in acute respiratory distress syndrome: a prospective metabolic profiling cohort study
2025 · European journal of medical research · 1 citations
https://doi.org/10.1186/s40001-025-03043-y
Baseline and changes in inflammatory parameters for patients with <scp><i>EGFR</i></scp>‐mutated <scp>NSCLC</scp> treated with afatinib
2025 · Thoracic Cancer · 0 citations
https://doi.org/10.1111/1759-7714.15338
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat